MRI parameters for prediction of multiple sclerosis diagnosis in children with acute CNS demyelination: a prospective national cohort study
Summary Background Multiple sclerosis (MS) diagnostic criteria incorporate MRI features that can be used to predict later diagnosis of MS in adults with acute CNS demyelination. To identify MRI predictors of a subsequent MS diagnosis in a paediatric population, we created a standardised scoring meth...
Gespeichert in:
Veröffentlicht in: | Lancet neurology 2011-12, Vol.10 (12), p.1065-1073 |
---|---|
Hauptverfasser: | , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1073 |
---|---|
container_issue | 12 |
container_start_page | 1065 |
container_title | Lancet neurology |
container_volume | 10 |
creator | Verhey, Leonard H, BSc Branson, Helen M, MBBS Shroff, Manohar M, MD Callen, David JA, MD Sled, John G, PhD Narayanan, Sridar, PhD Sadovnick, A Dessa, Prof Bar-Or, Amit, MD Arnold, Douglas L, Prof Marrie, Ruth Ann, MD Banwell, Brenda, Dr |
description | Summary Background Multiple sclerosis (MS) diagnostic criteria incorporate MRI features that can be used to predict later diagnosis of MS in adults with acute CNS demyelination. To identify MRI predictors of a subsequent MS diagnosis in a paediatric population, we created a standardised scoring method and applied it to MRI scans from a national prospective incidence cohort of children with CNS demyelination. Methods Clinical and MRI examinations were done at the onset of acute CNS demyelination and every 3 months in the first year after that, and at the time of a second demyelinating attack. MS was diagnosed on the basis of clinical or MRI evidence of relapsing disease. Baseline MRI scans were assessed for the presence of 14 binary response parameters. Parameters were assessed with a multiple tetrachoric correlation matrix. Univariate analyses and multivariable Cox proportional hazards models were used to identify predictors of MS. Findings Between Sept 1, 2004, and June 30, 2010, 332 children and adolescents were assessed for eligibility. 1139 scans were available from 284 eligible participants who had been followed up for 3·9 (SD 1·7) years. 57 (20%) were diagnosed with MS after a median of 188 (IQR 144–337) days. Seven of 14 binary response parameters were retained. The presence of either one or more T1-weighted hypointense lesions (hazard ratio 20·6, 95% CI 5·46–78·0) or one or more periventricular lesions (3·34, 1·27–8·83) was associated with an increased likelihood of MS diagnosis (sensitivity 84%, specificity 93%, positive predictive value 76%, negative predictive value 96%). Risk for MS diagnosis was highest when both parameters were present (34·27, 16·69–70·38). Although the presence of contrast enhancement, cerebral white matter, intracallosal, and brainstem lesions was associated with MS in the univariate analyses, these parameters were not retained in the multivariable models. Interpretation Specific MRI parameters can be used to predict diagnosis of MS in children with incident demyelination of the CNS. The ability to promptly identify children with MS will enhance timely access to care and will be important for future clinical trials in paediatric MS. Funding Canadian Multiple Sclerosis Scientific Research Foundation. |
doi_str_mv | 10.1016/S1474-4422(11)70250-2 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_912917046</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1474442211702502</els_id><sourcerecordid>912917046</sourcerecordid><originalsourceid>FETCH-LOGICAL-c530t-ec4821bfce10c85eadad0a7708769b71bf0488abf5aac55a125d319fb0e293a83</originalsourceid><addsrcrecordid>eNqFkU1v1DAQhi0Eou3CTwBZXCiHgMeJEy8HEFrxUamAROFsOfaEdUniYCdF-xv40zibZQ-99OTR-J1nPl5CngB7CQzKV1dQVEVWFJyfA7yoGBcs4_fI6SFdivvHmPMTchbjNWMcCgkPyQnnrKzKXJySv5-_XdBBB93hiCHSxgc6BLTOjM731De0m9rRDS3SaFoMPrpIrdM_-33kemq2rrUBe_rHjVuqzTQi3Xy5oha7Hbau1zPoNdUJ6-OAiXuDdMnqlhq_9WGkcZzs7hF50Og24uPDuyI_Prz_vvmUXX79eLF5d5kZkbMxQ1NIDnVjEJiRArXVlumqYrIq13WVflghpa4bobURQgMXNod1UzPk61zLfEWeL9w00e8J46g6Fw22re7RT1Gtga-hYkV5t5JVIEuesCvy7Jby2k8hbTiLhJRQFnNjsYhMOkUM2KghuE6HnQKmZlfV3lU1W6YA1N5VxVPd0wN8qju0x6r_NibB20WA6Ww3DoOKxmFvko8hXVxZ7-5s8eYWwSTvnNHtL9xhPC4DKnLFFsjMANgTeP4PQc3Iag</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>905881648</pqid></control><display><type>article</type><title>MRI parameters for prediction of multiple sclerosis diagnosis in children with acute CNS demyelination: a prospective national cohort study</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Verhey, Leonard H, BSc ; Branson, Helen M, MBBS ; Shroff, Manohar M, MD ; Callen, David JA, MD ; Sled, John G, PhD ; Narayanan, Sridar, PhD ; Sadovnick, A Dessa, Prof ; Bar-Or, Amit, MD ; Arnold, Douglas L, Prof ; Marrie, Ruth Ann, MD ; Banwell, Brenda, Dr</creator><creatorcontrib>Verhey, Leonard H, BSc ; Branson, Helen M, MBBS ; Shroff, Manohar M, MD ; Callen, David JA, MD ; Sled, John G, PhD ; Narayanan, Sridar, PhD ; Sadovnick, A Dessa, Prof ; Bar-Or, Amit, MD ; Arnold, Douglas L, Prof ; Marrie, Ruth Ann, MD ; Banwell, Brenda, Dr ; for the Canadian Pediatric Demyelinating Disease Network ; Canadian Pediatric Demyelinating Disease Network</creatorcontrib><description>Summary Background Multiple sclerosis (MS) diagnostic criteria incorporate MRI features that can be used to predict later diagnosis of MS in adults with acute CNS demyelination. To identify MRI predictors of a subsequent MS diagnosis in a paediatric population, we created a standardised scoring method and applied it to MRI scans from a national prospective incidence cohort of children with CNS demyelination. Methods Clinical and MRI examinations were done at the onset of acute CNS demyelination and every 3 months in the first year after that, and at the time of a second demyelinating attack. MS was diagnosed on the basis of clinical or MRI evidence of relapsing disease. Baseline MRI scans were assessed for the presence of 14 binary response parameters. Parameters were assessed with a multiple tetrachoric correlation matrix. Univariate analyses and multivariable Cox proportional hazards models were used to identify predictors of MS. Findings Between Sept 1, 2004, and June 30, 2010, 332 children and adolescents were assessed for eligibility. 1139 scans were available from 284 eligible participants who had been followed up for 3·9 (SD 1·7) years. 57 (20%) were diagnosed with MS after a median of 188 (IQR 144–337) days. Seven of 14 binary response parameters were retained. The presence of either one or more T1-weighted hypointense lesions (hazard ratio 20·6, 95% CI 5·46–78·0) or one or more periventricular lesions (3·34, 1·27–8·83) was associated with an increased likelihood of MS diagnosis (sensitivity 84%, specificity 93%, positive predictive value 76%, negative predictive value 96%). Risk for MS diagnosis was highest when both parameters were present (34·27, 16·69–70·38). Although the presence of contrast enhancement, cerebral white matter, intracallosal, and brainstem lesions was associated with MS in the univariate analyses, these parameters were not retained in the multivariable models. Interpretation Specific MRI parameters can be used to predict diagnosis of MS in children with incident demyelination of the CNS. The ability to promptly identify children with MS will enhance timely access to care and will be important for future clinical trials in paediatric MS. Funding Canadian Multiple Sclerosis Scientific Research Foundation.</description><identifier>ISSN: 1474-4422</identifier><identifier>EISSN: 1474-4465</identifier><identifier>DOI: 10.1016/S1474-4422(11)70250-2</identifier><identifier>PMID: 22067635</identifier><identifier>CODEN: LANCAO</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Acute Disease ; Adolescence ; Adolescent ; Brain - pathology ; Brain research ; Brain stem ; Central nervous system ; Child ; Children ; Clinical trials ; Cohort analysis ; Demyelinating Diseases - diagnosis ; Demyelinating Diseases - pathology ; Demyelination ; Female ; Humans ; Magnetic Resonance Imaging ; Male ; Multiple sclerosis ; Multiple Sclerosis - diagnosis ; Multiple Sclerosis - pathology ; Nerve Fibers, Myelinated - pathology ; Neurology ; Pediatrics ; Predictive Value of Tests ; Prognosis ; Prospective Studies ; Substantia alba</subject><ispartof>Lancet neurology, 2011-12, Vol.10 (12), p.1065-1073</ispartof><rights>Elsevier Ltd</rights><rights>2011 Elsevier Ltd</rights><rights>Copyright © 2011 Elsevier Ltd. All rights reserved.</rights><rights>Copyright Elsevier Limited Dec 2011</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c530t-ec4821bfce10c85eadad0a7708769b71bf0488abf5aac55a125d319fb0e293a83</citedby><cites>FETCH-LOGICAL-c530t-ec4821bfce10c85eadad0a7708769b71bf0488abf5aac55a125d319fb0e293a83</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S1474442211702502$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22067635$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Verhey, Leonard H, BSc</creatorcontrib><creatorcontrib>Branson, Helen M, MBBS</creatorcontrib><creatorcontrib>Shroff, Manohar M, MD</creatorcontrib><creatorcontrib>Callen, David JA, MD</creatorcontrib><creatorcontrib>Sled, John G, PhD</creatorcontrib><creatorcontrib>Narayanan, Sridar, PhD</creatorcontrib><creatorcontrib>Sadovnick, A Dessa, Prof</creatorcontrib><creatorcontrib>Bar-Or, Amit, MD</creatorcontrib><creatorcontrib>Arnold, Douglas L, Prof</creatorcontrib><creatorcontrib>Marrie, Ruth Ann, MD</creatorcontrib><creatorcontrib>Banwell, Brenda, Dr</creatorcontrib><creatorcontrib>for the Canadian Pediatric Demyelinating Disease Network</creatorcontrib><creatorcontrib>Canadian Pediatric Demyelinating Disease Network</creatorcontrib><title>MRI parameters for prediction of multiple sclerosis diagnosis in children with acute CNS demyelination: a prospective national cohort study</title><title>Lancet neurology</title><addtitle>Lancet Neurol</addtitle><description>Summary Background Multiple sclerosis (MS) diagnostic criteria incorporate MRI features that can be used to predict later diagnosis of MS in adults with acute CNS demyelination. To identify MRI predictors of a subsequent MS diagnosis in a paediatric population, we created a standardised scoring method and applied it to MRI scans from a national prospective incidence cohort of children with CNS demyelination. Methods Clinical and MRI examinations were done at the onset of acute CNS demyelination and every 3 months in the first year after that, and at the time of a second demyelinating attack. MS was diagnosed on the basis of clinical or MRI evidence of relapsing disease. Baseline MRI scans were assessed for the presence of 14 binary response parameters. Parameters were assessed with a multiple tetrachoric correlation matrix. Univariate analyses and multivariable Cox proportional hazards models were used to identify predictors of MS. Findings Between Sept 1, 2004, and June 30, 2010, 332 children and adolescents were assessed for eligibility. 1139 scans were available from 284 eligible participants who had been followed up for 3·9 (SD 1·7) years. 57 (20%) were diagnosed with MS after a median of 188 (IQR 144–337) days. Seven of 14 binary response parameters were retained. The presence of either one or more T1-weighted hypointense lesions (hazard ratio 20·6, 95% CI 5·46–78·0) or one or more periventricular lesions (3·34, 1·27–8·83) was associated with an increased likelihood of MS diagnosis (sensitivity 84%, specificity 93%, positive predictive value 76%, negative predictive value 96%). Risk for MS diagnosis was highest when both parameters were present (34·27, 16·69–70·38). Although the presence of contrast enhancement, cerebral white matter, intracallosal, and brainstem lesions was associated with MS in the univariate analyses, these parameters were not retained in the multivariable models. Interpretation Specific MRI parameters can be used to predict diagnosis of MS in children with incident demyelination of the CNS. The ability to promptly identify children with MS will enhance timely access to care and will be important for future clinical trials in paediatric MS. Funding Canadian Multiple Sclerosis Scientific Research Foundation.</description><subject>Acute Disease</subject><subject>Adolescence</subject><subject>Adolescent</subject><subject>Brain - pathology</subject><subject>Brain research</subject><subject>Brain stem</subject><subject>Central nervous system</subject><subject>Child</subject><subject>Children</subject><subject>Clinical trials</subject><subject>Cohort analysis</subject><subject>Demyelinating Diseases - diagnosis</subject><subject>Demyelinating Diseases - pathology</subject><subject>Demyelination</subject><subject>Female</subject><subject>Humans</subject><subject>Magnetic Resonance Imaging</subject><subject>Male</subject><subject>Multiple sclerosis</subject><subject>Multiple Sclerosis - diagnosis</subject><subject>Multiple Sclerosis - pathology</subject><subject>Nerve Fibers, Myelinated - pathology</subject><subject>Neurology</subject><subject>Pediatrics</subject><subject>Predictive Value of Tests</subject><subject>Prognosis</subject><subject>Prospective Studies</subject><subject>Substantia alba</subject><issn>1474-4422</issn><issn>1474-4465</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNqFkU1v1DAQhi0Eou3CTwBZXCiHgMeJEy8HEFrxUamAROFsOfaEdUniYCdF-xv40zibZQ-99OTR-J1nPl5CngB7CQzKV1dQVEVWFJyfA7yoGBcs4_fI6SFdivvHmPMTchbjNWMcCgkPyQnnrKzKXJySv5-_XdBBB93hiCHSxgc6BLTOjM731De0m9rRDS3SaFoMPrpIrdM_-33kemq2rrUBe_rHjVuqzTQi3Xy5oha7Hbau1zPoNdUJ6-OAiXuDdMnqlhq_9WGkcZzs7hF50Og24uPDuyI_Prz_vvmUXX79eLF5d5kZkbMxQ1NIDnVjEJiRArXVlumqYrIq13WVflghpa4bobURQgMXNod1UzPk61zLfEWeL9w00e8J46g6Fw22re7RT1Gtga-hYkV5t5JVIEuesCvy7Jby2k8hbTiLhJRQFnNjsYhMOkUM2KghuE6HnQKmZlfV3lU1W6YA1N5VxVPd0wN8qju0x6r_NibB20WA6Ww3DoOKxmFvko8hXVxZ7-5s8eYWwSTvnNHtL9xhPC4DKnLFFsjMANgTeP4PQc3Iag</recordid><startdate>20111201</startdate><enddate>20111201</enddate><creator>Verhey, Leonard H, BSc</creator><creator>Branson, Helen M, MBBS</creator><creator>Shroff, Manohar M, MD</creator><creator>Callen, David JA, MD</creator><creator>Sled, John G, PhD</creator><creator>Narayanan, Sridar, PhD</creator><creator>Sadovnick, A Dessa, Prof</creator><creator>Bar-Or, Amit, MD</creator><creator>Arnold, Douglas L, Prof</creator><creator>Marrie, Ruth Ann, MD</creator><creator>Banwell, Brenda, Dr</creator><general>Elsevier Ltd</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0TZ</scope><scope>3V.</scope><scope>7RV</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88G</scope><scope>8AO</scope><scope>8C2</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M2M</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20111201</creationdate><title>MRI parameters for prediction of multiple sclerosis diagnosis in children with acute CNS demyelination: a prospective national cohort study</title><author>Verhey, Leonard H, BSc ; Branson, Helen M, MBBS ; Shroff, Manohar M, MD ; Callen, David JA, MD ; Sled, John G, PhD ; Narayanan, Sridar, PhD ; Sadovnick, A Dessa, Prof ; Bar-Or, Amit, MD ; Arnold, Douglas L, Prof ; Marrie, Ruth Ann, MD ; Banwell, Brenda, Dr</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c530t-ec4821bfce10c85eadad0a7708769b71bf0488abf5aac55a125d319fb0e293a83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Acute Disease</topic><topic>Adolescence</topic><topic>Adolescent</topic><topic>Brain - pathology</topic><topic>Brain research</topic><topic>Brain stem</topic><topic>Central nervous system</topic><topic>Child</topic><topic>Children</topic><topic>Clinical trials</topic><topic>Cohort analysis</topic><topic>Demyelinating Diseases - diagnosis</topic><topic>Demyelinating Diseases - pathology</topic><topic>Demyelination</topic><topic>Female</topic><topic>Humans</topic><topic>Magnetic Resonance Imaging</topic><topic>Male</topic><topic>Multiple sclerosis</topic><topic>Multiple Sclerosis - diagnosis</topic><topic>Multiple Sclerosis - pathology</topic><topic>Nerve Fibers, Myelinated - pathology</topic><topic>Neurology</topic><topic>Pediatrics</topic><topic>Predictive Value of Tests</topic><topic>Prognosis</topic><topic>Prospective Studies</topic><topic>Substantia alba</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Verhey, Leonard H, BSc</creatorcontrib><creatorcontrib>Branson, Helen M, MBBS</creatorcontrib><creatorcontrib>Shroff, Manohar M, MD</creatorcontrib><creatorcontrib>Callen, David JA, MD</creatorcontrib><creatorcontrib>Sled, John G, PhD</creatorcontrib><creatorcontrib>Narayanan, Sridar, PhD</creatorcontrib><creatorcontrib>Sadovnick, A Dessa, Prof</creatorcontrib><creatorcontrib>Bar-Or, Amit, MD</creatorcontrib><creatorcontrib>Arnold, Douglas L, Prof</creatorcontrib><creatorcontrib>Marrie, Ruth Ann, MD</creatorcontrib><creatorcontrib>Banwell, Brenda, Dr</creatorcontrib><creatorcontrib>for the Canadian Pediatric Demyelinating Disease Network</creatorcontrib><creatorcontrib>Canadian Pediatric Demyelinating Disease Network</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Pharma and Biotech Premium PRO</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Neurosciences Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>ProQuest Pharma Collection</collection><collection>Lancet Titles</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest Psychology</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Lancet neurology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Verhey, Leonard H, BSc</au><au>Branson, Helen M, MBBS</au><au>Shroff, Manohar M, MD</au><au>Callen, David JA, MD</au><au>Sled, John G, PhD</au><au>Narayanan, Sridar, PhD</au><au>Sadovnick, A Dessa, Prof</au><au>Bar-Or, Amit, MD</au><au>Arnold, Douglas L, Prof</au><au>Marrie, Ruth Ann, MD</au><au>Banwell, Brenda, Dr</au><aucorp>for the Canadian Pediatric Demyelinating Disease Network</aucorp><aucorp>Canadian Pediatric Demyelinating Disease Network</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>MRI parameters for prediction of multiple sclerosis diagnosis in children with acute CNS demyelination: a prospective national cohort study</atitle><jtitle>Lancet neurology</jtitle><addtitle>Lancet Neurol</addtitle><date>2011-12-01</date><risdate>2011</risdate><volume>10</volume><issue>12</issue><spage>1065</spage><epage>1073</epage><pages>1065-1073</pages><issn>1474-4422</issn><eissn>1474-4465</eissn><coden>LANCAO</coden><abstract>Summary Background Multiple sclerosis (MS) diagnostic criteria incorporate MRI features that can be used to predict later diagnosis of MS in adults with acute CNS demyelination. To identify MRI predictors of a subsequent MS diagnosis in a paediatric population, we created a standardised scoring method and applied it to MRI scans from a national prospective incidence cohort of children with CNS demyelination. Methods Clinical and MRI examinations were done at the onset of acute CNS demyelination and every 3 months in the first year after that, and at the time of a second demyelinating attack. MS was diagnosed on the basis of clinical or MRI evidence of relapsing disease. Baseline MRI scans were assessed for the presence of 14 binary response parameters. Parameters were assessed with a multiple tetrachoric correlation matrix. Univariate analyses and multivariable Cox proportional hazards models were used to identify predictors of MS. Findings Between Sept 1, 2004, and June 30, 2010, 332 children and adolescents were assessed for eligibility. 1139 scans were available from 284 eligible participants who had been followed up for 3·9 (SD 1·7) years. 57 (20%) were diagnosed with MS after a median of 188 (IQR 144–337) days. Seven of 14 binary response parameters were retained. The presence of either one or more T1-weighted hypointense lesions (hazard ratio 20·6, 95% CI 5·46–78·0) or one or more periventricular lesions (3·34, 1·27–8·83) was associated with an increased likelihood of MS diagnosis (sensitivity 84%, specificity 93%, positive predictive value 76%, negative predictive value 96%). Risk for MS diagnosis was highest when both parameters were present (34·27, 16·69–70·38). Although the presence of contrast enhancement, cerebral white matter, intracallosal, and brainstem lesions was associated with MS in the univariate analyses, these parameters were not retained in the multivariable models. Interpretation Specific MRI parameters can be used to predict diagnosis of MS in children with incident demyelination of the CNS. The ability to promptly identify children with MS will enhance timely access to care and will be important for future clinical trials in paediatric MS. Funding Canadian Multiple Sclerosis Scientific Research Foundation.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>22067635</pmid><doi>10.1016/S1474-4422(11)70250-2</doi><tpages>9</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1474-4422 |
ispartof | Lancet neurology, 2011-12, Vol.10 (12), p.1065-1073 |
issn | 1474-4422 1474-4465 |
language | eng |
recordid | cdi_proquest_miscellaneous_912917046 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | Acute Disease Adolescence Adolescent Brain - pathology Brain research Brain stem Central nervous system Child Children Clinical trials Cohort analysis Demyelinating Diseases - diagnosis Demyelinating Diseases - pathology Demyelination Female Humans Magnetic Resonance Imaging Male Multiple sclerosis Multiple Sclerosis - diagnosis Multiple Sclerosis - pathology Nerve Fibers, Myelinated - pathology Neurology Pediatrics Predictive Value of Tests Prognosis Prospective Studies Substantia alba |
title | MRI parameters for prediction of multiple sclerosis diagnosis in children with acute CNS demyelination: a prospective national cohort study |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T12%3A49%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=MRI%20parameters%20for%20prediction%20of%20multiple%20sclerosis%20diagnosis%20in%20children%20with%20acute%20CNS%20demyelination:%20a%20prospective%20national%20cohort%20study&rft.jtitle=Lancet%20neurology&rft.au=Verhey,%20Leonard%20H,%20BSc&rft.aucorp=for%20the%20Canadian%20Pediatric%20Demyelinating%20Disease%20Network&rft.date=2011-12-01&rft.volume=10&rft.issue=12&rft.spage=1065&rft.epage=1073&rft.pages=1065-1073&rft.issn=1474-4422&rft.eissn=1474-4465&rft.coden=LANCAO&rft_id=info:doi/10.1016/S1474-4422(11)70250-2&rft_dat=%3Cproquest_cross%3E912917046%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=905881648&rft_id=info:pmid/22067635&rft_els_id=S1474442211702502&rfr_iscdi=true |